Brief: AN2 Therapeutics Inc - Approved A Reduction In Force That Is Intended To Result In Termination Of Approximately 50% Of Company's Employee Workforce

AN2 Therapeutics

08/08/2024 23:35

Aug 8 (Reuters) - AN2 Therapeutics Inc  ANTX.O :
    * AN2 THERAPEUTICS INC - APPROVED A REDUCTION IN FORCE THAT
IS
INTENDED TO RESULT IN TERMINATION OF APPROXIMATELY 50% OF
COMPANY'S EMPLOYEE WORKFORCE
    * AN2 THERAPEUTICS INC - AS RESULT OF REDUCTION IN FORCE,
ESTIMATES THAT IT WILL INCUR AGGREGATE CHARGES OF ABOUT $2-$3
MILLION
    * AN2 THERAPEUTICS:AS PART OF RESTRUCTURING PAUL ECKBURG,
CMO, TO
DEPART EFFECTIVE AS OF AUGUST 30

Source text for Eikon:  ID:n0001193125-24-197047 
Further company coverage:  ANTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))